SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Escalating U.S.-Iran tensions and uncertainty over negotiations are driving attention to DJT, with traders focused on potential military action, Strait of Hormuz disruptions, higher energy costs, and broader inflation and economic risk. Supporters view Trumps foreign-policy moves as strengthening U.S. security, while critics argue the conflict, rising fuel costs, and media restrictions are damaging the economy and his political standing.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after traders attributed its sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, reinforcing the projects privacy, AI-agent and cross-chain trading narrative. The community is broadly bullish and discussing further momentum, though some traders view the move as a liquidity-driven pump and expect consolidation or a pullback.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

SpaceXs IPO-related selloff and concerns about upcoming insider share unlocks are driving attention, with traders saying the ETFs sizable SpaceX exposure has pressured the broader space basket. Sentiment is split between frustration over continued weakness and bullish long-term investors averaging down on the space-sector theme.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Traders are reacting to the announced U.S.-Denmark-Greenland security agreement, viewing greater U.S. strategic involvement and limits on rival investment as a potential tailwind for CRMLs Tanbreez rare-earth project and the broader critical-minerals sector. The community is split between bullish short-squeeze and sector-re-rating expectations and caution that the pact does not directly fund the mine or change its development timeline.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

U.S. government backing and efforts to build a China-independent rare-earth and magnet supply chain are driving attention, alongside concerns about Chinese export restrictions and U.S.-China talks. Traders cite MPs DoD support, price-floor protections and planned GM magnet deliveries as long-term positives, while some warn that easing China tensions and recent technical weakness could pressure the stock in the near term.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

The proposed Tempus acquisition of Personalis is driving attention, with traders focused on merger approval, exchange-ratio and regulatory risks. Many view the deal as undervaluing Personalisparticularly given its MRD technology and links to Merck/Modernas personalized cancer-vaccine workand are urging a no vote or speculating about a competing bid, while others expect the transaction to close.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Attention centers on Starknets privacy and BTCFi push, particularly the rollout of strkBTC and STRK20, alongside its STARK-based post-quantum security narrative. Traders are reacting to the sharp rebound and reported breakout with bullish long-term conviction, though others cite token unlocks, dilution, and weak technical structure as risks.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Speculation around a potential POSCO strategic partnership remains the main focus, with traders debating whether a deal will be finalized or abandoned and how it could affect Cleveland-Cliffs valuation and debt position. The discussion is reinforced by improving hot-rolled steel prices, expectations for stronger upcoming results, and elevated short interest, prompting both short-squeeze optimism and skepticism over leverage and profitability.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy is drawing attention after its fiscal Q3 update showed production ramping but no uranium sales, prompting concerns about near-term revenue, operating costs and valuation. Traders remain divided, with bears focused on execution and dilution risk while bulls point to the companys cash-rich, debt-free balance sheet, unhedged inventory and longer-term U.S. nuclear-fuel demand.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Repeated open-market purchases by CEO Troy Wilson, including another 100,000-share buy, are driving attention and being viewed by traders as a confidence signal in Kuras oncology pipeline and KOMZIFTI launch. The community is broadly bullish and watching for short covering, though some traders remain cautious about valuation, commercialization execution, and biotech risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
